STUDY OF THE ANTITUMOR ACTIVITY OF THE CHLORINE E6 AND VANDETANIB CONJUGATE AS AN AGENT FOR COMBINED PHOTODYNAMIC AND TARGETED THERAPY
- Authors: Krylova L.V1, Peskova N.N1, Volovetsky A.B1, Pronina S.Y.1, Otvagin V.F1, Kuzmina N.S1, Fedorov A.Y.1, Balalaeva I.V1
-
Affiliations:
- Lobachevsky University
- Issue: Vol 15, No 3S (2020)
- Pages: 54-54
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/122650
- DOI: https://doi.org/10.23868/gc122650
- ID: 122650
Cite item
Open Access
Access granted
Abstract
Full Text
About the authors
L. V Krylova
Lobachevsky University
Email: lu.krylova@mail.ru
Nizhny Novgorod, Russia
N. N Peskova
Lobachevsky UniversityNizhny Novgorod, Russia
A. B Volovetsky
Lobachevsky UniversityNizhny Novgorod, Russia
S. Yu Pronina
Lobachevsky UniversityNizhny Novgorod, Russia
V. F Otvagin
Lobachevsky UniversityNizhny Novgorod, Russia
N. S Kuzmina
Lobachevsky UniversityNizhny Novgorod, Russia
A. Yu Fedorov
Lobachevsky UniversityNizhny Novgorod, Russia
I. V Balalaeva
Lobachevsky UniversityNizhny Novgorod, Russia
References
- Otvagin V.F. et al. Water-Soluble Chlorin/Arylaminoquinazoline Conjugate for Photodynamic and Targeted Therapy // J. Med. Chem. 2019; 62, 11182-11193.
Supplementary files
